Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Austria Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20142
20151
20201
20213
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
AOP Orphan Pharmaceuticals AG2
Amgen1
Ariad Pharmaceuticals1
Novartis Pharmaceuticals1
Pfizer1
Sierra Oncology LLC - a GSK company1
Sunesis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases12
Bone Marrow Diseases5
Myeloproliferative Disorders5
Lymphoma, B-Cell4
Lymphoma, Non-Hodgkin4
Leukemia, Lymphocytic, Chronic, B-Cell3
Neoplasms3
Polycythemia Vera3
Leukemia2
Lymphoma2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.